Shilpa Gupta: Philippe Spiess kicks off the session on rare GU cancers in Athens!

Shilpa Gupta shared a post on X:

“The amazing Philippe Spiess kicks off the session on rare GU cancers in Athens! The definition of ‘rare’ cancers depends on where one lives. Urgent need to tackle the unmet needs globally & get them the $$ & attention they deserve.”

Source: Shilpa Gupta/X

Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.